Corelation Between Symptomatic Relief and Regression of Mucosal Findings in Allergic Rhinitis after Treatment with Intranasal Fluticasone Propionate
DOI:
https://doi.org/10.48047/Keywords:
Allergic Rhinitis, Fluticasone Propionate nasal spray, Total Nasal Symptom Score TNSS, Diagnostic Nasal endoscopy.Abstract
Background: Allergic Rhinitis is an inflammatory, IgE-mediated disease nasal mucosa
characterized by nasal congestion, rhinorrhea, paroxysmal sneezing, and/or nasal itching. It is
a common and often debilitating disease, which can have a major detrimental impact on
quality-of-life and social productivity based on which it can be classified as mild or
moderately-severe. The management of allergic rhinitis includes avoidance of allergen,
pharmacotherapy, and disease modifying immunotherapy. Our study is aimed to correlate the
response of patient’s symptomatic relief with the regression of mucosal findings on
diagnostic nasal endoscopy with fluticasone propionate nasal spray. Objectives: 1. To classify
allergic rhinitis patients as MILD and MODERATELY- SEVERE based on the total
symptoms and sign score.
